Is RDH12 gene therapy available in China?

Yes, RDH12 gene therapy is associated with clinical research and licensed medical use in the Hainan Boao Lecheng Pilot Zone. It is not yet available nationwide.

How much does RDH12 gene therapy cost in China?

The estimated cost is ¥480,000 (approximately US$71,400) per eye. Confirm final pricing and the scope of included services directly with the hospital.

Who may qualify for RDH12 gene therapy in China?

The treatment is associated with inherited retinal disease caused by RDH12 gene mutations. Detailed patient-level eligibility criteria are not specified, so final eligibility requires assessment by the treating medical team.